Date:- From 2020-07-01 to 2020-07-04
For more information about this event, visit the website
HalioDx team is glad to announce its participation in the coming ESMO GI Annual meeting, which will be held for the first time in a virtual format.
This annual event is an opportunity to share scientific research advances and clinical insights in GI cancers.
This year again, Immunoscore® will be highlighted in two oral presentations.
You will have the opportunity to learn more about Immunoscore® and get access to the latest scientific updates on our comprehensive clinical program , aimed at a utilizing patient’s immune system to predict recurrence, survival and response to therapies in localized colon cancer.
Our presenters :
Dr Marjane Le Bagousse :
“Host immunity at the tumor site helps tailor clinical strategies
Immunoscore® up-to-date evidence in colon cancers”
Wednesday, 1 July 2020- 1:15 PM – 2:15 PM
Jérôme Galon, PhD :
“A TNM-Immune (TNM-I) classification staging system for predicting survival in colon cancer in a multicenter international SITC study”
Friday, 3 July – 1:39 PM – 1:49 PM